Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
22:28:02 EDT Thu 03 Oct 2024
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:KPTI - KARYOPHARM THERAPEUTICS INC - http://www.karyopharm.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
KPTI - Q0.10.8048·0.920.10.881-0.0029-0.31,803.01,4791,8830.88  0.929  0.84011.95  0.617418:03:30Oct 0115 min RT 2¢

Recent Trades - Last 10 of 1883
Time ETExPriceChangeVolume
18:03:30Q0.8741-0.0098137
17:52:11Q0.8624-0.02151
17:52:11Q0.8626-0.0213137
16:20:35Q0.8647-0.019210
16:00:02Q0.881-0.0029566
16:00:02Q0.881-0.0029608
16:00:02Q0.881-0.0029527
16:00:02Q0.881-0.0029487
16:00:02Q0.881-0.0029446
16:00:02Q0.881-0.002976

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-10-01 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-09-03 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-09-03 07:00U:KPTINews ReleaseKaryopharm to Participate at Upcoming Investor Conferences
2024-08-06 07:30U:KPTINews ReleaseKaryopharm Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
2024-08-01 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-07-31 16:05U:KPTINews ReleaseKaryopharm to Report Second Quarter 2024 Financial Results on August 6, 2024
2024-07-01 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-06-03 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-06-01 13:45U:KPTINews ReleaseKaryopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates
2024-05-29 16:05U:KPTINews ReleaseKaryopharm to Participate at the Jefferies Global Healthcare Conference
2024-05-08 16:05U:KPTINews ReleaseKaryopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference
2024-05-08 07:30U:KPTINews ReleaseKaryopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029
2024-05-08 07:30U:KPTINews ReleaseKaryopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
2024-05-02 16:30U:KPTINews ReleaseKaryopharm to Report First Quarter 2024 Financial Results on May 8, 2024
2024-05-01 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-04-24 16:01U:KPTINews ReleaseKaryopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting
2024-04-01 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-03-06 16:05U:KPTINews ReleaseKaryopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences
2024-03-01 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-02-29 07:30U:KPTINews ReleaseKaryopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress